Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics (Q80342487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1 reference

11

Hartmut Goldschmidt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Friedrich W Cremer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jelena Bila

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Isabelle Buck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mutlu Kartal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dirk Hose

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Carina Ittrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Axel Benner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marc S Raab

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ann-Cathrin Theil

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marion Moos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Claus R Bartram

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Anna Jauch

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

194-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma

30 December 2019

cites work

1 reference

7 January 2021

Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis

1 reference

7 January 2021

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

1 reference

7 January 2021

Distance-based reconstruction of tree models for oncogenesis.

1 reference

7 January 2021

Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.

1 reference

7 January 2021

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

1 reference

7 January 2021

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

1 reference

7 January 2021

Genetics and cytogenetics of multiple myeloma: a workshop report.

1 reference

7 January 2021

Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?

1 reference

7 January 2021

Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization

1 reference

7 January 2021

Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma

1 reference

7 January 2021

IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases

1 reference

7 January 2021

Advances in biology of multiple myeloma: clinical applications

1 reference

7 January 2021

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

1 reference

7 January 2021

The (11;14)(q13;q32) Translocation in Multiple Myeloma

1 reference

7 January 2021

High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis

1 reference

7 January 2021

Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.

1 reference

7 January 2021

Non-random karyotypic evolution in chronic myeloid leukemia

1 reference

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

7 January 2021

The clonal evolution of tumor cell populations

1 reference

7 January 2021

A strategy for the characterization of minute chromosome rearrangements using multiple color fluorescence in situ hybridization with chromosome-specific DNA libraries and YAC clones

1 reference

7 January 2021

Molecular aspects of multiple myeloma

1 reference

7 January 2021

Rare occurrence of P53 gene mutations in multiple myeloma

1 reference

7 January 2021

Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma

1 reference

7 January 2021

Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination

1 reference

7 January 2021

Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes

1 reference

7 January 2021

Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma

1 reference

7 January 2021

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

1 reference

7 January 2021

New insights into the pathophysiology of multiple myeloma

1 reference

7 January 2021

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

1 reference

7 January 2021

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

7 January 2021

Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases

1 reference

7 January 2021

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.

1 reference

7 January 2021

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

1 reference

7 January 2021

Maximum likelihood estimation of oncogenetic tree models

1 reference

7 January 2021

Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma

1 reference

7 January 2021

N-ras and p53 gene mutations are very rare events in multiple myeloma

1 reference

7 January 2021

Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profiling

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001433%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference